pharmaphorum

OCTOBER 26, 2022

Boehringer Ingelheim has moved one of its top pipeline prospects – oral phosphodiesterase 4B (PDE4B) inhibitor BI 1015550 – into late-stage clinical testing for idiopathic pulmonary fibrosis and other interstitial lung diseases (ILDs). There are more than 200 lung disorders that can lead to pulmonary fibrosis.

Recruitment 98

Recruitment Prospecting Marketing Patients 98

Quantified

SEPTEMBER 21, 2023

through 2029. Use Cases for AI Tools for Sales The sales cycle is often divided into seven stages, from lead generation to completing a sale. AI Tools for Acquiring and Qualifying Leads Lead generation involves marketing campaigns, attending tradeshows, and making cold calls. The process is time and labor intensive.

Sales 52

Sales Prospecting Training Sales tools 52

European Pharmaceutical Review

JUNE 16, 2023

According to Maximize Market Research , new technologies are expected to boost the clinical trials market between 2022 to 2029, especially as the industry and patients are shifting towards digitalisation approaches and personalised medicines. As the data landscape evolves, what is the most exciting innovation in clinical data management.

Safety 111

Safety Electronics Recruitment Patients 111

Spotio

MAY 7, 2024

billion in the US alone by 2029. In other words, there’s plenty of opportunity—as long as you know how to generate telecom sales leads effectively, of course. Keep reading to learn about ideal customer profiles, unique value propositions, and other prospecting techniques you can use to boost telecom leads.

Leads 52

Leads Sales Prospecting Distribution 52

Pharmaceutical Technology

MAY 17, 2023

This results in bile buildup in the liver and can lead to scarring. billion in 2029. We highlight the most impactful emerging technologies, as well as the industry, regulatory, and macroeconomic factors that influence growth prospects. The condition gradually worsens and can result in liver failure.

Food and Drug Administration 52

Food and Drug Administration FDA Pharmaceutical Prospecting 52